← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2025-05-20

Drug application

FDA Application #

ANDA209530

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

JUBILANT GENERICS

First approval

2025-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown